Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2025-12-28 @ 4:04 AM
Study NCT ID:
NCT04680468
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-15
First Post:
2020-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
Sponsor:
University of Pennsylvania
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-11
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-02
First Submit QC Date:
None
Study First Post Date:
2020-12-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED